Chidamide Bridging for CAR-T Therapy

NCT05370547 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin's Lymphoma

Interventions

DRUG: Chidamide
DRUG: Fludarabine and cyclophosphamide
BIOLOGICAL: Anti-CD19 CAR-T cells

Sponsor

Chinese PLA General Hospital